Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Validation of ferroptosis-sensitizing combination therapies in patient-derived neuroblastoma models

Information

Project Team

Outputs and Outcomes

Publications

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

Emily Van SanAngela DebruyneGeraldine VeeckmansYulia Y. Y. TyurinaVladimir A. A. TyurinHao ZhengSze Men ChoiKoen AugustynsGeert van LooBernhard MichalkeVivek VenkataramaniShinya ToyokuniHuelya BayirPeter VandenabeeleBehrouz HassanniaTom Vanden Berghe et al.

A1 Journal Article in CELL DEATH AND DIFFERENTIATION

2023

Ferroptosis and pyroptosis signatures in critical COVID-19 patients

Cédric PelemanSamya Van CoillieSymen LigthartSze Men ChoiJan De WaelePieter DepuydtDominique BenoitHANNAH SCHAUBROECKSven M. FrancqueKarolien DamsRita JacobsDominique RobertRia RoelandtRuth SeurinckYvan SaeysMohan RajapurkarPhilippe G. JorensEric HosteTom Vanden Berghe et al.

A1 Journal Article in CELL DEATH AND DIFFERENTIATION

2023

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

Samya Van CoillieEmily Van SanInes GoetschalckxBartosz WiernickiBanibrata MukhopadhyayWulf TonnusSze Men ChoiRia RoelandtCatalina DumitrascuLudwig LambertsGeert DamsWannes WeytsJelle HuysentruytBehrouz HassanniaIrina IngoldSuhas LeleEvelyne MeyerMaya BergRuth SeurinckYvan SaeysAn VermeulenAlexander L. N. van NuijsMarcus ConradAndreas LinkermannMohan RajapurkarPeter VandenabeeleEric HosteKoen AugustynsTom Vanden Berghe et al.

A1 Journal Article in NATURE COMMUNICATIONS

2022